Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

A study to evaluate the efficacy, safety, and tolerability of using an oral once-daily 2 drug regimen compared to an oral once-daily 3 drug … Ended

2023-504993-40-00 Human immunodeficiency virus (HIV) 5 2024-02-14
Prospective study to evaluate the efficacy of letermovir prophylaxis for the prevention of CMV infection in lung transplant recipients compa… Ended

2023-504384-16-00 lung transplant patients (D+/R-) 4 2023-12-18
Therapeutic vaccination: Phase I / II clinical study on patients randomized blinded to the experimental vaccine or placebo regimen. we want … Ended

2024-514581-39-00 HIV Infection 7 2023-11-08
A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Fluad and Fluad … Ended

2022-503004-24-00 Influenza virus 5 2023-10-20
A phase I trial to assess safety and immunogenicity of an HLAII-targeted DNA vaccine against influenza H7N9 Ended

2022-500706-18-01 Influenza prophylaxis 1 2023-09-11
A Phase 1/2a Study of Safety, Pharmacokinetics and Neutralizing Activity of SPK002 as pre-exposure prophylaxis of COVID-19 in healthy volunt… Ended

2023-505279-62-00 Immunocompromised individuals (phase 2a) 7 2023-07-10
A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression i… Ended

2024-520388-15-00 HIV-infected 5 2023-06-30
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen Ended

2022-500929-33-01 Human Immunodeficiency Virus (HIV-1) infection 10 2023-05-17
Antiviral treatment for long covid. Ended

2023-510337-29-00 Virus Diseases 5 2023-04-11
Immunogenicity of 9-valent HPV vaccine in immunocompromised children and adolescents Ended

2022-501413-31-00 Immunosuppressed patients 11 2023-03-07
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection Ended

2022-501901-10-00 Chronic Hepatitis D Infection 6 2023-02-06
A pilot open label phase I trial to evaluate the safety and the tolerability of a combination of two HIV-1 inducers in HIV+ sub-type B patie… Ended

2024-518141-13-00 HIV 3 2022-12-05
A Study to Evaluate Investigational Therapies in Chronic Hepatitis D Virus Infection. Ended

2024-512203-40-00 Chronic Hepatitis D Virus (HDV) Infection 4 2022-11-24
A study on the long-term efficacy, safety and persistence of immune response of a vaccine against Herpes Zoster in older adults. Ended

2023-505255-51-00 Herpes Zoster 5 2022-08-08
Live Attenuated Rift Valley Fever Vaccine for Single Shot Administration (LARISSA) Ended

2022-501460-17-00 Rift Valley fever (RVF) infection 1 2022-07-26
A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects wi… Ended

2024-513177-48-00 Chronic Hepatitis B Virus Infection 4 2022-06-16
Long-term follow-up study to evaluate durability of treatment response in previous bepirovirsen study participants (B-Sure). Ended

2023-506867-33-01 Chronic Hepatitis B 4 2022-01-25
ANRS HB07 IP-Cure-B proof of concept (PoC) clinical trial. Educating the liver immune environment through TLR8 stimulation followed by NUC d… Ended

2024-515739-32-00 HBV 4 2022-01-10
Clinical trial to evaluate Metformin compared with placebo for reversal of accelerated aging in persons living with HIV 50 years or older Ended

2024-512287-54-00 HIV infection 8 2021-12-03
DOR/ISL Open-label Rollover Trial Ended

2024-512215-53-00 HIV infection 5 2021-10-27
Study on an Investigational Yellow Fever Vaccine Compared with Stamaril in Adults in Europe and Asia Ended

2022-502047-35-00 Yellow fever 4 2021-10-07
Early DOlutegravir/LAmivudine Switching after virological suppression (EDOLAS Study) Ended

2024-518909-18-00 HIV-1 infected individuals currently taking an INSTI-ba 5 2021-03-23
Immunogenicity, safety, reactogenicity and persistence of an investigational respiratory syncytial virus (RSV) vaccine in adults aged 60 yea… Ended

2024-512291-34-00 Respiratory Syncytial Virus Infections 5 2021-02-22
A roll-over study with rilpivirine for human immunodeficiency virus type 1 (HIV-1) infected subjects who participated in rilpivirine pediatr… Ended

2024-512889-33-00 HIV-1 Infection 4 2021-01-30